Ran Hu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Comparative safety assessment of measles-containing vaccination schedules in Jiangsu Province, China: A population-based pharmacovigilance study (2014-2024).

Comparative safety assessment of measles-containing vaccination schedules in Jiangsu Province, China: A population-based pharmacovigilance study (2014-2024).

Journal: Human vaccines & immunotherapeutics

Published: June 17, 2026

Evaluation of Hepatitis B Vaccine Immunogenicity in Low-Birth-Weight Infants After Complete Immunization: The Impact of Postnatal Catch-Up Growth and Maternal-Neonatal Characteristics.

Evaluation of Hepatitis B Vaccine Immunogenicity in Low-Birth-Weight Infants After Complete Immunization: The Impact of Postnatal Catch-Up Growth and Maternal-Neonatal Characteristics.

Journal: Vaccines

Published: May 26, 2026

An active surveillance study of adverse events following to Japanese encephalitis inactivated vaccine (JE-I) in Jiangsu Province, China, 2024-2025.

An active surveillance study of adverse events following to Japanese encephalitis inactivated vaccine (JE-I) in Jiangsu Province, China, 2024-2025.

Journal: Expert review of vaccines

Published: April 14, 2026

Epidemiological analysis and exploration of prevention and control strategies for breakthrough cases of varicella in Jiangsu Province China.

Epidemiological analysis and exploration of prevention and control strategies for breakthrough cases of varicella in Jiangsu Province China.

Journal: Human vaccines & immunotherapeutics

Published: April 07, 2026

Safety of an SV-1 Cell Line-Based Varicella Vaccine Before and After Integration into the Expanded Program on Immunization: A Real-World Study in Jiangsu Province, China.

Safety of an SV-1 Cell Line-Based Varicella Vaccine Before and After Integration into the Expanded Program on Immunization: A Real-World Study in Jiangsu Province, China.

Journal: Vaccines

Published: January 13, 2026

Safety Evaluation of Large-Scale Administration of a Novel Human Diploid (SV-1) Cell Line-Derived Varicella Attenuated Live Vaccine in Children 7-12 Years Old.

Safety Evaluation of Large-Scale Administration of a Novel Human Diploid (SV-1) Cell Line-Derived Varicella Attenuated Live Vaccine in Children 7-12 Years Old.

Journal: Vaccines

Published: November 29, 2025

Active Surveillance of Adverse Events Following Influenza Immunization in Jiangsu Province, China: A 2019-2023 Retrospective Study.

Active Surveillance of Adverse Events Following Influenza Immunization in Jiangsu Province, China: A 2019-2023 Retrospective Study.

Journal: Vaccines

Published: September 22, 2025

High Prevalence of Macrolide-resistant ptxP3-prn150 Bordetella pertussis in Jiangsu Province, China, 2024.

High Prevalence of Macrolide-resistant ptxP3-prn150 Bordetella pertussis in Jiangsu Province, China, 2024.

Journal: The Pediatric infectious disease journal

Published: September 09, 2025

Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China.

Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China.

Journal: Human vaccines & immunotherapeutics

Published: January 19, 2025

Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023.

Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023.

Journal: BMC infectious diseases

Published: March 04, 2024

Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China.

Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China.

Journal: Frontiers in public health

Published: August 04, 2023

The Rapid End of Poliovirus Excreting in a Primary Immunodeficiency Patient After Gamma Globulin Supplement Administration.

The Rapid End of Poliovirus Excreting in a Primary Immunodeficiency Patient After Gamma Globulin Supplement Administration.

Journal: The Pediatric infectious disease journal

Published: July 06, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026